Yo Seol, one of the first graduating members of the master’s program at the Pritzker School of Molecular Engineering at the University of Chicago, is passionate about bettering human life through improving medical technology.
Although Seol has long been keen on pursuing a career in engineering, it was his medical diagnosis that steered him into biotechnology.
While studying as an undergraduate and graduate student, Seol was diagnosed with and treated for cancer. He recalls his experience not just dealing with surgery but struggling with the resulting health issues from it, which he says could have been improved with precision (or personalized) medicine and technology.
“It’s not about just being diagnosed and getting the right surgery to remove a tumor,” Seol said about precision medicine, “it’s also the aftercare where patients could struggle because their bodies are going through a huge anomaly. Not all medical devices or medicine fits every person, so I wanted to study how we can focus on each patient, which we call precision medicine.”
After graduating from the Georgia Institute of Technology and working in an energy and cardiac-specific department of a biomedical company, Seol decided to join the master’s program at Pritzker Molecular Engineering. He joined the program’s polymer science and engineering track with some immunoengineering courses as electives.